Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation for Acute Intestinal GVHD
NCT04711967Unknown
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Mar 2021
- Primary completion
- Jul 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Trial of allogeneic fecal microbiota in graft-versus-host disease (GVHD) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: Change in times of stool at day 28 and Change in volume of stool at day 28. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT04711967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04711967.